Molbio Diagnostics IPO Opens: ₹904 Cr Issue, Anchor Investors Commit ₹281 Cr
Source: Mint Markets
Arth Insight · What this means for your wallet
- You have an opportunity to invest in a new company, potentially yielding capital gains if its share price rises post-listing.
- Investing in this IPO ties up your capital, which could be at risk if the company's shares perform poorly after listing.
- Participation requires a Demat account and funds, potentially diverting money from other savings or investment avenues.
Wealth-Impact Simulator
See what a one-time investment could grow to.
Indicative estimate for education only — not investment advice.
Explore investmentsMolbio Diagnostics' Initial Public Offering (IPO) opened for subscription today, August 10, aiming to raise between ₹904 crore and ₹940 crore. The company has already secured ₹281.5 crore from anchor investors, signalling strong institutional interest.
- ▸Molbio Diagnostics IPO is open from August 10 to August 12.
- ▸The company aims to raise up to ₹940 crore.
- ▸₹281.5 crore was raised from anchor investors prior to the IPO.
- ▸Funds will be used for expansion and R&D.
- ✓Molbio Diagnostics IPO is open from August 10 to August 12.
- ✓The company aims to raise up to ₹940 crore.
- ✓₹281.5 crore was raised from anchor investors prior to the IPO.
- ✓Funds will be used for expansion and R&D.
The IPO of Molbio Diagnostics, a company specializing in point-of-care diagnostic solutions, commenced on August 10, with the subscription window set to close on August 12. The company plans to raise ₹904 crore to ₹940 crore through this public offering.
Before the public issue opened, Molbio Diagnostics successfully garnered ₹281.5 crore from anchor investors. This pre-IPO fundraising round saw participation from several prominent funds, indicating confidence in the company's business model and growth prospects.
The funds raised from the IPO are earmarked for significant expansion initiatives and bolstering the company's research and development (R&D) capabilities. This strategic investment aims to enhance Molbio Diagnostics' product portfolio and market reach in the rapidly growing diagnostics sector.
Molbio Diagnostics is known for its innovative diagnostic solutions designed for rapid testing at the point of care, making healthcare more accessible and efficient, particularly in remote areas.
This information is for educational purposes only and does not constitute investment advice.
Community Pulse · This story
How readers rate the outlook after reading this article. Anonymous · one vote per reader · updates live.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.
Frequently Asked Questions
When does the Molbio Diagnostics IPO open and close?
The IPO opened on August 10 and will close on August 12.
How much money is Molbio Diagnostics looking to raise?
The company aims to raise between ₹904 crore and ₹940 crore through the IPO.
Who are the anchor investors in Molbio Diagnostics IPO?
Molbio Diagnostics secured ₹281.5 crore from anchor investors, including major funds, prior to the public offering.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about Stock Market
IPOBreakingLEAP India IPO Day 2: Grey Market Premium at ₹16, Listing Price Estimated at ₹175
The LEAP India IPO saw its Grey Market Premium (GMP) at ₹16 on the second day of its subscription period. This suggests an estimated listing price of ₹175 per share, based on the upper end of the IPO price band.
IPOBreakingTechnocraft Ventures IPO: Grey Market Premium Jumps to ₹21 on Day 2
The grey market premium (GMP) for Technocraft Ventures' Initial Public Offering (IPO) has risen to ₹21 per share on its second day. This indicates a potential listing gain for investors.
IPOBreakingArdee Industries IPO Allotment: Check Status Online and Latest Grey Market Premium
Ardee Industries is set to finalize its IPO share allotment following a successful subscription period. Investors can now verify their application status online via the registrar's portal or the BSE website while tracking the latest grey market trends.
Related Stories
IPOBreakingLEAP India IPO Day 2: Grey Market Premium at ₹16, Listing Price Estimated at ₹175
The LEAP India IPO saw its Grey Market Premium (GMP) at ₹16 on the second day of its subscription period. This suggests an estimated listing price of ₹175 per share, based on the upper end of the IPO price band.
IPOBreakingTechnocraft Ventures IPO: Grey Market Premium Jumps to ₹21 on Day 2
The grey market premium (GMP) for Technocraft Ventures' Initial Public Offering (IPO) has risen to ₹21 per share on its second day. This indicates a potential listing gain for investors.
IPOBreakingArdee Industries IPO Allotment: Check Status Online and Latest Grey Market Premium
Ardee Industries is set to finalize its IPO share allotment following a successful subscription period. Investors can now verify their application status online via the registrar's portal or the BSE website while tracking the latest grey market trends.
Delhivery Q1 Profit Dips 65% Despite 28% Revenue Jump; Vani Venkatesh Appointed Deputy CEO
Logistics major Delhivery reported a significant 65% decrease in its Q1 profit, even as the company saw a 28% rise in revenue. Alongside the financial results, Delhivery announced the immediate elevation of Vani Venkatesh to the position of Deputy CEO, enhancing its leadership team.